Edoardo Cignoli : Valeant Pharma Swings to Profit

Valeant Pharmaceuticals swung to a fourth-quarter profit as its revenue surged following its $8.7 billion acquisition of Bausch & Lomb.



via WSJ.com: US Business http://ift.tt/1fL6ZoU